Michael Sobolik

Michael Sobolik is a senior fellow at Hudson Institute and author of Countering China’s Great Game: A Strategy for American Dominance.

America’s Trump card in China

From our US edition

The Trump administration has released a list of CEOs who will be accompanying the president to his meeting in China with Xi Jinping. Foremost among the delegation is Elon Musk, traveling in his capacity as CEO of Tesla and SpaceX. Another notable inclusion is Tim Cook, in what may be his swan song international trip as Apple CEO. All told, 17 executives will accompany President Trump to the People’s Republic of China (PRC). Their companies represent sectors ranging from banking and investment to automobiles and AI. Their asks of Xi will likely range from market access (Coherent) and advertising (Meta) to component orders (Boeing) and soybean purchases (Cargill). On paper, President Trump should take business leaders with him to China.

Trump

China targets US citizens with biowarfare weapons

From our US edition

On June 3 the Department of Justice announced charges against two nationals of the People’s Republic of China (PRC). The offenses ranged from conspiracy and false statements to visa fraud and smuggling. The final charge was the most concerning, as the item in question was a fungus called Fusarium graminearum. According to DOJ, this fungus is “a potential agroterrorism weapon” responsible for head blight, a disease that targets multiple crops from wheat and maize to barley and rice. It causes billions of dollars in economic losses worldwide each year, and its effects are pronounced: vomiting, liver damage, and reproductive disruptions in both humans and livestock. Welcome to the newest front in the Chinese Communist party’s (CCP) cold war against Americans.

Biowarfare